Company: RPTX
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030405
Chunk: 1

Company: Repare Therapeutics Inc.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 15
Chunk 1
---
(a)The following documents are filed as a part of this Annual Report:

(1)Consolidated Financial Statements:

Our Consolidated Financial Statements are listed in the “Index to Consolidated Financial Statements” under Part II, Item 8 of this Annual Report. 

(2)Financial Statement Schedules:

All financial statement schedules have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes herein.

(3)Exhibits:

The documents listed in the following Exhibit Index of this Annual Report are incorporated by reference or are filed with this Annual Report on Form 10-K, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K). 

142

Exhibit Index

    Incorporated by Reference

    ExhibitNumber
     
    Description
     
    ScheduleForm
     
    File Number
     
    Exhibit
     
    Filing Date

      3.1
     
    Articles of Continuance of Repare Therapeutics Inc. 
     
    8-K
     
    001-39335
     
    3.1
     
    June 23, 2020

      3.2
     
    Amended and Restated Bylaws of Repare Therapeutics Inc.
     
    8-K
     
    001-39335
     
    3.2
     
    June 23, 2020

      4.1
     
    Form of Common Share Certificate of the registrant.
     
    S-1
     
    333-238822
     
    4.1
     
    June 15, 2020

      4.2* 
     
    Warrant to Purchase Common Shares issued to Astr Partners LLC, dated November 7, 2024. 

      4.3
     
    Description of Registrant’s Securities.
     
    10-K
     
    001-39335
     
    4.4
     
    March 4, 2021

    10.1+
     
    Repare Therapeutics Inc. Amended and Restated Option Plan.
     
    S-1
     
    333-238822
     
    10.1
     
    May 29, 2020

    10.2